HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C-Reactive Protein and Inflammatory Cytokines during Percutaneous Coronary Intervention.

AbstractBACKGROUND:
C-reactive protein (CRP) is significantly associated with cardiovascular diseases; however, whether CRP plays a causal role in coronary artery disease has yet to be determined. In addition, the relationship between CRP, atherosclerosis, and inflammation remains controversial.
METHODS AND RESULTS:
Serum interleukin (IL)-6, IL-1β, and CRP levels were determined in 160 patients at time points around percutaneous coronary intervention (PCI) with drug-eluting stent implantation. The levels were found to be at peak at 24 h post-PCI and gradually declined to the level before PCI at day 30 post-PCI. These inflammation markers around PCI have no statistical difference in the different postdilation pressures (≤14, 14-18, and ≥18 atm) and stent number (1 and ≥2 stents) groups. Treatment of cultured human vascular smooth muscle cells (VSMCs) with a combination of IL-6 and IL-1β at concentrations associated with PCI did not result in any significant change in the CRP mRNA levels. The IL-6-augmented CRP expression in human internal mammary arteries (IMAs) stretched with a mechanical strength of 3 g was blocked by the nuclear factor-κB (NF-κB) peptide inhibitor SN50 and not by the inactive SN50 analog SN50M. IL-6 treatment increased NF-κB activity in human IMAs stretched with 3 g, and this effect was further blocked by stretch-activated channel (SAC) inhibitors (streptomycin or GdCl3) and SN50.
CONCLUSIONS:
The current study provides evidence that increased serum IL-6, IL-1β, and CRP levels around PCI are not different between different postdilation pressure and stent number groups. The combination of IL-6 and IL-1β at concentrations associated with PCI cannot induce CRP expression in human VSMCs, but they can augment mechanical strain-induced CRP synthesis via the SAC-NF-κB pathway in human IMAs.
AuthorsMingxin Wu, Xinyuan Gu, Xiujuan Li, Yanhui Li, Huaineng Zhou, Guihua Lu, ZhongKai Wu, He Huang, Lilong Tang, Jianping Zeng
JournalJournal of vascular research (J Vasc Res) Vol. 53 Issue 1-2 Pg. 39-48 ( 2016) ISSN: 1423-0135 [Electronic] Switzerland
PMID27487299 (Publication Type: Journal Article)
Copyright© 2016 S. Karger AG, Basel.
Chemical References
  • IL1B protein, human
  • IL6 protein, human
  • Inflammation Mediators
  • Interleukin-1beta
  • Interleukin-6
  • Ion Channels
  • NF-kappa B
  • C-Reactive Protein
Topics
  • Aged
  • Angioplasty, Balloon, Coronary (instrumentation)
  • C-Reactive Protein (genetics, metabolism)
  • Cells, Cultured
  • Coronary Artery Disease (blood, diagnostic imaging, genetics, therapy)
  • Drug-Eluting Stents
  • Female
  • Gene Expression Regulation
  • Humans
  • Inflammation Mediators (blood)
  • Interleukin-1beta (blood)
  • Interleukin-6 (blood)
  • Ion Channel Gating
  • Ion Channels (metabolism)
  • Male
  • Mammary Arteries (metabolism)
  • Mechanotransduction, Cellular
  • Middle Aged
  • Muscle, Smooth, Vascular (metabolism)
  • Myocytes, Smooth Muscle (metabolism)
  • NF-kappa B (metabolism)
  • Pressure
  • Stress, Mechanical
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: